Mehdi Farshchian is a Dermatology physician affiliated with University of California, Los Angeles. OpenAlex indexes 101 publications with 1,607 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2020 Santa Monica Blvd Ste 510
Santa Monica, CA 904042131
Telephone
310-917-3376Provider last certified this registry record 29 Jul 2022.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202510 payments
- Amgen Inc.Program year202512 payments
- Galderma Laboratories, L.P.Program year202518 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
28.8%Azole Antifungal19.8%Ketoconazole100%Part D≥103 patientsTetracycline-class Drug3.3%Doxycycline Monohydrate100%Part D≥22 patients+ 2 more classes in this area
Dermatology
24.7%Corticosteroid10%Triamcinolone Acetonide100%Part D≥81 patientsInterleukin-4 Receptor alpha Antagonist7.1%Dupixent Pen86%Dupixent Syringe14%Part D<11 patients+ 3 more classes in this area
Sensory organs
14.6%Corticosteroid14.6%Clobetasol Propionate64%Hydrocortisone29%Betamethasone Dipropionate7%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of Solar Lentigines: A Systematic Review of Clinical Trials
Journal of Cosmetic Dermatology
2025 - Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics
Dermatology and Therapy
2022 - Medical Student Confidence in Diagnosis of Dermatologic Diseases in Skin of Color
Clinical Cosmetic and Investigational Dermatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”